The Molecular Bacterial Load Assay Replaces Solid Culture for Measuring Early Bactericidal Response to Antituberculosis Treatment

ABSTRACT We evaluated the use of the molecular bacterial load (MBL) assay, for measuring viable Mycobacterium tuberculosis in sputum, in comparison with solid agar and liquid culture. The MBL assay provides early information on the rate of decline in bacterial load and has technical advantages over culture in either form.

• Publication year

  2014

• Venue

  Journal of Clinical Microbiology

• Publication date

  2014-05-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JCM.01128-14PMID 24871215PMCID PMC4136187
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Direct Comparison of Xpert MTB/RIF Assay with Liquid and Solid Mycobacterial Culture for Quantification of Early Bactericidal Activity

  2013cited by this paper
• Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.

  2013cited by this paper
• Probability of Negative Mycobacterium tuberculosis Complex Cultures Based on Time to Detection of Positive Cultures: a Multicenter Evaluation of Commercial-Broth-Based Culture Systems

  2012cited by this paper
• 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.

  2012cited by this paper
• Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents.

  2012cited by this paper
• Molecular Bacterial Load Assay, a Culture-Free Biomarker for Rapid and Accurate Quantification of Sputum Mycobacterium tuberculosis Bacillary Load during Treatment

  2011cited by this paper
• Resuscitation-promoting factors reveal an occult population of tubercle Bacilli in Sputum.

  2010cited by this paper
• Sputum Mycobacterium tuberculosis mRNA as a Marker of Bacteriologic Clearance in Response to Antituberculosis Therapy

  2009cited by this paper
• A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.

  2008cited by this paper
• Use of Nonlinear Mixed-Effects Analysis for Improved Precision of Early Pharmacodynamic Measures in Tuberculosis Treatment

  2006cited by this paper
• Meta-Analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without Solid Media, for Detection of Mycobacteria

  2004cited by this paper
• Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.

  2003cited by this paper
• Early bactericidal activity of antituberculosis agents

  2003cited by this paper
• Formation and resuscitation of "non-culturable" cells of Rhodococcus rhodochrous and Mycobacterium tuberculosis in prolonged stationary phase.

  2002cited by this paper
• Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling

  2002cited by this paper
• A reiterative method for calculating the early bactericidal activity of antituberculosis drugs.

  2002cited by this paper
• Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis

  2001cited by this paper
• The estimation of the bactericidal power of the blood

  1938cited by this paper

• Revolutionizing diagnosis of pulmonary Mycobacterium tuberculosis based on CT: a systematic review of imaging analysis through deep learning

  2025cites this paper
• High centrifugation speed improves recovery of M. tuberculosis and yield of culture.

  2025cites this paper
• Exploring Mycobacterium tuberculosis rRNA Transcriptomic Signatures as Response to Anti-TB Treatment in Whole Blood RNA-seq Data

  2025cites this paper
• Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TB

  2024cites this paper
• A stool based qPCR for the diagnosis of TB in children and people living with HIV in Uganda, Eswatini and Mozambique (Stool4TB): a protocol for a multicenter diagnostic evaluation

  2024cites this paper
• Acetic Acid Enables Molecular Enumeration of Mycobacterium tuberculosis from Sputum and Eliminates the Need for a Biosafety Level 3 Laboratory.

  2024cites this paper
• Improving the diagnosis of tuberculosis: old and new laboratory tools

  2024cites this paper
• The Molecular Bacterial Load Assay predicts treatment responses in patients with pre-XDR/XDR-tuberculosis more accurately than GeneXpert Ultra MTB/Rif.

  2024cites this paper
• Advances in tuberculosis biomarkers: unravelling risk factors, active disease and treatment success

  2024cites this paper
• New Insights into Biomarkers for Evaluating Therapy Efficacy in Pulmonary Tuberculosis: A Narrative Review

  2023cites this paper
• Early bactericidal activity studies for pulmonary tuberculosis: a systematic review of methodological aspects.

  2023cites this paper
• Performance of Tuberculosis Molecular Bacterial Load Assay Compared to Alere TB-LAM in Urine of Pulmonary Tuberculosis Patients with HIV Co-Infections

  2023cites this paper
• CD38 Expression by Antigen-Specific CD4 T Cells Is Significantly Restored 5 Months After Treatment Initiation Independently of Sputum Bacterial Load at the Time of Tuberculosis Diagnosis

  2022influential citation
• Culture-Free Enumeration of Mycobacterium tuberculosis in Mouse Tissues Using the Molecular Bacterial Load Assay for Preclinical Drug Development

  2022cites this paper
• CD38 expression by antigen-specific CD4 T cells correlates with sputum bacterial load at time of tuberculosis diagnosis and is significantly restored 5-months after treatment initiation.

  2022influential citation
• High Mycobacterium tuberculosis Bacillary Loads Detected by Tuberculosis Molecular Bacterial Load Assay in Patient Stool: a Potential Alternative for Nonsputum Diagnosis and Treatment Response Monitoring of Tuberculosis

  2022cites this paper
• Building sustainable clinical trial sites in Sub-Saharan Africa through networking, infrastructure improvement, training and conducting clinical studies: The PanACEA approach.

  2022cites this paper
• A practical approach to render tuberculosis samples safe for application of tuberculosis molecular bacterial load assay in clinical settings without a biosafety level 3 laboratory.

  2022cites this paper
• Systematic assessment of clinical and bacteriological markers for tuberculosis reveals discordance and inaccuracy of symptom-based diagnosis for treatment response monitoring

  2022cites this paper
• Reduction of blood C-reactive protein concentration complements the resolution of sputum bacillary load in patients on anti-tuberculosis therapy

  2022cites this paper
• Tuberculosis Molecular Bacterial Load Assay Reveals Early Delayed Bacterial Killing in Patients With Relapse

  2022cites this paper
• Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies

  2022cites this paper
• Reproducibility of the Ribosomal RNA Synthesis Ratio in Sputum and Association with Markers of <named-content content-type='genus-species'>Mycobacterium tuberculosis</named-content> Burden

  2021cites this paper
• Lipid droplets and the transcriptome of Mycobacterium tuberculosis from direct sputa: a literature review

  2021cites this paper
• Reproducibility of the Ribosomal RNA Synthesis Ratio in Sputum and Association with Markers of Mycobacterium tuberculosis Burden

  2021cites this paper
• Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania

  2021cites this paper
• Transcriptome signature of cell viability predicts drug response and drug interaction for Tuberculosis

  2021cites this paper
• Evaluation of the molecular bacterial load assay for detecting viable Mycobacterium tuberculosis in cerebrospinal fluid before and during tuberculous meningitis treatment

  2021cites this paper
• Perspectives for systems biology in the management of tuberculosis

  2021cites this paper
• Molecular bacterial load assay versus culture for monitoring treatment response in adults with tuberculosis

  2021cites this paper
• Position statement on innovative clinical trial design for development of new TB treatments

  2021cites this paper
• Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments

  2021cites this paper
• Biomarkers That Correlate with Active Pulmonary Tuberculosis Treatment Response: a Systematic Review and Meta-analysis

  2021cites this paper
• Transcriptome signature of cell viability predicts drug response and drug interaction in Mycobacterium tuberculosis

  2021cites this paper
• LSHTM Research

  2020cites this paper
• Deploying a novel tuberculosis molecular bacterial load assay to assess the elimination rate of Mycobacterium tuberculosis in patients with multidrug-resistant tuberculosis in Tanzania

  2020cites this paper
• Pneumonia caused by Mycobacterium tuberculosis

  2020cites this paper
• A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA).

  2020cites this paper
• Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay

  2020cites this paper
• United Kingdom–East and Southern Africa Partnership at the Forefront of Developing the First Ever Test that Measures Patient Tuberculosis Burden in Hours

  2019cites this paper
• High-dose rifampicin, moxifl oxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

  2019cites this paper
• Heat Inactivation Renders Sputum Safe and Preserves Mycobacterium tuberculosis RNA for Downstream Molecular Tests

  2019cites this paper
• improving diagnosis and monitoring of treatment response in pulmonary tuberculosis using the molecular bacterial load assay (MBLA)

  2019cites this paper
• Quantification of viable bacterial load in artificial sputum spiked with Mycobacterium tuberculosis.

  2019cites this paper
• Pharmacometric Models to Improve the Treatment and Development of Drugs against Tuberculosis

  2019influential citation
• Molecular Bacterial Load Assay Concurs with Culture on NaOH-Induced Loss of Mycobacterium tuberculosis Viability

  2019cites this paper
• Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid Culture

  2019cites this paper
• Detection of Mycobacterium tuberculosis RNA in bioaerosols from pulmonary tuberculosis patients.

  2019cites this paper
• Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs

  2019cites this paper
• Comparison of the Mycobacterium tuberculosis molecular bacterial load assay, microscopy and GeneXpert versus liquid culture for viable bacterial load quantification before and after starting pulmonary tuberculosis treatment

  2019cites this paper
• Tittle : Heat-inactivation renders sputum safe and preserves Mycobacterium 1 tuberculosis RNA for downstream molecular tests 2 Running tittle : Heat-inactivation of sputum preserves RNA 3

  2019cites this paper
• Using RT qPCR for Quantifying Mycobacteria marinum from In Vitro and In Vivo Samples.

  2018cites this paper
• The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis

  2018cites this paper
• The effects of co-morbidities on blood transcriptomes in tuberculosis patients before and during treatment

  2018cites this paper
• Meta-Narrative Review of Molecular Methods for Diagnosis and Monitoring of Multidrug-Resistant Tuberculosis Treatment in Adults

  2018cites this paper
• Can we predict tuberculosis cure? What tools are available?

  2018cites this paper
• OMNIgene.SPUTUM suppresses contaminants while maintaining Mycobacterium tuberculosis viability and obviates cold-chain transport

  2018cites this paper
• Characterising HIV-associated Mycobacterium tuberculosis blood stream infection

  2018cites this paper
• Molecular Biosensors for Electrochemical Detection of Infectious Pathogens in Liquid Biopsies: Current Trends and Challenges

  2017cites this paper
• A journal to highlight health research in EAC countries

  2017cites this paper
• Beyond the Numbers: Interpreting WHO's Global Tuberculosis Report 2016 to Inform TB Policy and Practice in the East African Community

  2017cites this paper
• Gridlock from Diagnosis to Treatment of Multidrug-Resistant Tuberculosis (MDR-TB) in Tanzania: Illuminating Potential Factors for Possible Intervention

  2017cites this paper
• Evaluation of potential surrogate markers to determine TB treatment response among TB patients in Mbeya, Tanzania

  2017influential citation
• The importance of clinical pharmacokinetic–pharmacodynamic studies in unraveling the determinants of early and late tuberculosis outcomes

  2017cites this paper
• What Are Clinically Relevant Levels of Cellular and Biomolecular Analytes?

  2017cites this paper
• Pediatric tuberculosis-human immunodeficiency virus co-infection in the United Kingdom highlights the need for better therapy monitoring tools: a case report

  2017cites this paper
• High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

  2017cites this paper
• Mycobacterial Load Assay.

  2017cites this paper
• Mycobacterium tuberculosis exploits the PPM1A signaling pathway to block host macrophage apoptosis

  2017cites this paper
• A comparison of solid and liquid culture in tuberculosis diagnosis and treatment monitoring

  2016cites this paper
• Changes in Host Cytokine Patterns of TB Patients with Different Bacterial Loads Detected Using 16S rRNA Analysis

  2016cites this paper
• Assessment of treatment response in tuberculosis

  2016cites this paper
• The use of digital PCR to improve the application of quantitative molecular diagnostic methods for tuberculosis

  2016cites this paper
• Phenotypically Adapted Mycobacterium tuberculosis Populations from Sputum Are Tolerant to First-Line Drugs

  2016cites this paper
• Mapping of Mycobacterium tuberculosis Complex Genetic Diversity Profiles in Tanzania and Other African Countries

  2016cites this paper
• Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings.

  2016cites this paper
• Challenges in the clinical assessment of novel tuberculosis drugs.

  2016cites this paper
• Improving the Tuberculosis Drug Development Pipeline

  2015cites this paper
• Shortening treatment of tuberculosis: lessons from fl uoroquinolone trials

  2015cites this paper
• Climate change and infectious disease: time for a new normal?

  2015cites this paper
• Shortening treatment of tuberculosis: lessons from fluoroquinolone trials.

  2015cites this paper
• Cytokine Kinetics in the First Week of Tuberculosis Therapy as a Tool to Confirm a Clinical Diagnosis and Guide Therapy

  2015cites this paper